2 resultsfor “Benefits of injectable pembrolizumab for cancer patients”
patients across [England](https://www.theguardian.com/uk-news/england) each year will benefit from a new immunotherapy treatment that can be used for several types of cancer, the NHS has announced. The injectable form of pembrolizumab
patients in England start on a course of Keytruda, also known as pembrolizumab, each year, with most of those likely to be moved over to the injectable version. The drug can currently be used